PHI with Raynaud's disease
How does this condition affect your private health insurance?
Raynaud's disease, or phenomenon, is a condition characterized by episodic vasospasm of small arteries, most commonly in the fingers and toes, in response to cold temperatures or emotional stress. This leads to distinctive color changes—white (ischemia), blue (cyanosis), and red (reperfusion)—accompanied by numbness, tingling, and pain. It can be primary (idiopathic and milder) or secondary, linked to underlying connective tissue diseases like scleroderma or lupus. While primary Raynaud's is generally benign, secondary forms can be severe, potentially leading to skin ulcers or gangrene in rare cases, significantly impacting quality of life.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Minutes to hours per episode
Duration of Illness (Lifetime)
Chronic, often lifelong with intermittent episodes; severity can fluctuate
Cost of Treatment (Initial)
Low (lifestyle changes, warm clothing) to moderate (initial doctor visit, medication if needed)
Cost of Treatment (Lifetime)
Low for primary Raynaud's (conservative management); moderate to high for secondary Raynaud's (ongoing medication, management of underlying disease, potential complications)
Mortality Rate
Very low directly from Raynaud's; higher if associated with severe underlying systemic diseases that cause secondary Raynaud's
Risk of Secondary Damages
Low in primary Raynaud's; moderate to high in severe secondary Raynaud's (e.g., digital ulcers, fingertip necrosis, gangrene in rare cases)
Probability of Full Recovery
Moderate for primary Raynaud's (symptoms may improve or resolve with age or trigger avoidance); low for secondary Raynaud's without successful treatment of the underlying condition
Underlying Disease Risk
Very low for primary Raynaud's (idiopathic); moderate to high for secondary Raynaud's (e.g., scleroderma, lupus, rheumatoid arthritis, Sjogren's syndrome, atherosclerosis)